SMAS - news) is pleased to announce that the Company is targeting the U.S. military in an effort to help relieve soldiers of chronic pain. Nationwide more than 41 percent of nearly 185,000 Iraq and Afghanistan veterans who sought care from the Veterans Administration reported muscular-skeletal problems, mostly from back and joint pain.
Somatic Systems, Inc. (More than 1.4 million active-duty uniformed personnel serve in the four branches of the Department of Defense, representing a potential multi-million dollar pain relief market. The Clinical Somatics™ technique combats unnecessary muscular contraction and associated pain often resulting from traumatic injury or chronic stress. The techniques offer a solution previously untested in the U.S. military.
"This is a unique opportunity for Somatic Systems and for the U.S. military. There are millions of active and retired military personnel who can benefit from our pain relief techniques. Our hope is that Clinical Somatics™ becomes one of the standard treatments for chronic pain for veterans," stated Somatic Systems, Inc. Chairman and CEO, Steve Aronstein.
Nearly 26 million living Americans have served in the military. Clinical Somatics™ uses a series of movements that restore muscles to their natural state. Clinical Somatics™ techniques have been tested on numerous members of the U.S. military with overwhelmingly positive results.
About Somatic Systems, Inc.
Somatic Systems, Inc. is headquartered in Northampton, Massachusetts. Somatics uses a technique called Clinical Somatics™. Somatics trains and certifies clinical practitioners on how to reeducate a client's muscles and recalibrate overused or injured muscles through a simple series of training sessions and prescribed at-home movements. The Clinical Somatics™ process uses a series of movements (lasting as little as five minutes a day) that lengthen muscles back to their natural, relaxed state.
Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information visit
http://www.somatics.org
or contact:
Investor Relations
1-877-586-2555
SOURCE: Somatic Systems, Inc.